1 | prevent | 17,821 |
2 | halt | 214 |
3 | forestall | 29 |
4 | debulk | 8 |
5 | pre-empt | 8 |
6 | debride | 7 |
7 | rejuvenate | 7 |
8 | prevent/delay | 5 |
9 | reconfigure | 5 |
10 | overdiagnose | 4 |
11 | symbolize | 4 |
12 | antecede | 2 |
13 | bls-level | 2 |
14 | crystalloidsalbumin | 2 |
15 | current/just-terminated | 2 |
16 | delay/prevent | 2 |
17 | gmw | 2 |
18 | non-bereavement | 2 |
19 | orthogenetic | 2 |
20 | reduce/prevent | 2 |
21 | resorb | 2 |
22 | retool | 2 |
23 | six-ring | 2 |
24 | tissue-volume | 2 |
25 | 'improve | 1 |
26 | 'neonate | 1 |
27 | 0.14+/-0.35 | 1 |
28 | 0.517±0.042 | 1 |
29 | 0.93±0.65 | 1 |
30 | 1,500u | 1 |
31 | 100tcid50 | 1 |
32 | 101,850 | 1 |
33 | 103,300 | 1 |
34 | 12.14.10 | 1 |
35 | 16.0±11.16 | 1 |
36 | 28-hours | 1 |
37 | 3,4-dihydro-2h-1,3-thiazine-containing | 1 |
38 | 3.3±2.4 | 1 |
39 | 32±3 | 1 |
40 | 35.6/100 | 1 |
41 | 36±16 | 1 |
42 | 49.06 | 1 |
43 | 5=preferred | 1 |
44 | 6,724,284 | 1 |
45 | 72-hours | 1 |
46 | 91,183 | 1 |
47 | acidosis-induced | 1 |
48 | activity/resisting | 1 |
49 | adpkd-associated | 1 |
50 | aglaothamnion | 1 |
51 | ameleriote | 1 |
52 | amoxycillin- | 1 |
53 | angled- | 1 |
54 | anoxia/reoxygenation | 1 |
55 | antihormone-resistant | 1 |
56 | binary- | 1 |
57 | bioverify | 1 |
58 | bladder-invasive | 1 |
59 | butorphan | 1 |
60 | c-23 | 1 |
61 | c.polykrikoides | 1 |
62 | carpenter-coustan | 1 |
63 | cat+act | 1 |
64 | cephazoline | 1 |
65 | chemoprevent | 1 |
66 | confidential/anonymous | 1 |
67 | continued-fluoxetine | 1 |
68 | control/suppress | 1 |
69 | counter-sorcerers | 1 |
70 | delary | 1 |
71 | diazotetramic | 1 |
72 | dii-negative | 1 |
73 | drug-use-related | 1 |
74 | eci™-guided | 1 |
75 | encoding/maintenance | 1 |
76 | evolutionary-derived | 1 |
77 | extracardial | 1 |
78 | gdm-a2 | 1 |
79 | gefitinib- | 1 |
80 | globalise | 1 |
81 | god/destiny | 1 |
82 | grip+tau | 1 |
83 | gtfb | 1 |
84 | gti-cn | 1 |
85 | hemiarthropasty | 1 |
86 | hispa- | 1 |
87 | htlv-i/ii | 1 |
88 | icn80 | 1 |
89 | inassayability | 1 |
90 | increase-cardiovascular | 1 |
91 | laser-powered | 1 |
92 | lc3-positive | 1 |
93 | less-soluble | 1 |
94 | limited-incision | 1 |
95 | lopinavir/ritonavir- | 1 |
96 | lymphangioleiomyomatosis-related | 1 |
97 | lysozyme-induced | 1 |
98 | mbs-identified | 1 |
99 | mono-alpha-glucoside | 1 |
100 | msm-sensitive | 1 |
101 | music-delivering | 1 |
102 | nonimmune-related | 1 |
103 | nontransthoracic | 1 |
104 | o-k-j-i-p | 1 |
105 | observation-alone | 1 |
106 | opioid-spare | 1 |
107 | orc/plnd | 1 |
108 | overthrow | 1 |
109 | par+uv-a | 1 |
110 | paraphrase | 1 |
111 | perineuraly | 1 |
112 | perirandomization | 1 |
113 | pique | 1 |
114 | pla- | 1 |
115 | placebo.only | 1 |
116 | podcast-only | 1 |
117 | postjoke | 1 |
118 | pre-external | 1 |
119 | pre-fc | 1 |
120 | pre/early | 1 |
121 | pregnancy/during | 1 |
122 | present- | 1 |
123 | promiscuity/multiple | 1 |
124 | promote/support | 1 |
125 | ps-tt | 1 |
126 | pseudo-cushing | 1 |
127 | pyrrolidine-fused | 1 |
128 | r5.00 | 1 |
129 | re-formulate | 1 |
130 | reacquire | 1 |
131 | rebreed | 1 |
132 | resuscitate/stabilise | 1 |
133 | rf-b7.1 | 1 |
134 | rhamnose-glucose | 1 |
135 | routine-to-optional | 1 |
136 | selectebrain | 1 |
137 | self-dna | 1 |
138 | self-feed | 1 |
139 | self-prevent | 1 |
140 | sicken | 1 |
141 | sidelining | 1 |
142 | sng | 1 |
143 | sones | 1 |
144 | splenopancreatic | 1 |
145 | sulphomethoxasol/trimethoprim | 1 |
146 | tacrine- | 1 |
147 | treatment-less | 1 |
148 | treatments-as-usual | 1 |
149 | uncircumcised-no | 1 |
150 | vadaskert | 1 |
151 | vildagliptin/metformin | 1 |
152 | zidovudine/lamivudine+efavirenz | 1 |
153 | zinc-insulin | 1 |
154 | ~44,000 | 1 |
155 | £30k | 1 |
156 | €951 | 1 |
1 | 'improve | 1 |
2 | 'neonate | 1 |
3 | 0.14+/-0.35 | 1 |
4 | 0.517±0.042 | 1 |
5 | 0.93±0.65 | 1 |
6 | 1,500u | 1 |
7 | 100tcid50 | 1 |
8 | 101,850 | 1 |
9 | 103,300 | 1 |
10 | 12.14.10 | 1 |
11 | 16.0±11.16 | 1 |
12 | 28-hours | 1 |
13 | 3,4-dihydro-2h-1,3-thiazine-containing | 1 |
14 | 3.3±2.4 | 1 |
15 | 32±3 | 1 |
16 | 35.6/100 | 1 |
17 | 36±16 | 1 |
18 | 49.06 | 1 |
19 | 5=preferred | 1 |
20 | 6,724,284 | 1 |
21 | 72-hours | 1 |
22 | 91,183 | 1 |
23 | acidosis-induced | 1 |
24 | activity/resisting | 1 |
25 | adpkd-associated | 1 |
26 | aglaothamnion | 1 |
27 | ameleriote | 1 |
28 | amoxycillin- | 1 |
29 | angled- | 1 |
30 | anoxia/reoxygenation | 1 |
31 | antecede | 2 |
32 | antihormone-resistant | 1 |
33 | binary- | 1 |
34 | bioverify | 1 |
35 | bladder-invasive | 1 |
36 | bls-level | 2 |
37 | butorphan | 1 |
38 | c-23 | 1 |
39 | c.polykrikoides | 1 |
40 | carpenter-coustan | 1 |
41 | cat+act | 1 |
42 | cephazoline | 1 |
43 | chemoprevent | 1 |
44 | confidential/anonymous | 1 |
45 | continued-fluoxetine | 1 |
46 | control/suppress | 1 |
47 | counter-sorcerers | 1 |
48 | crystalloidsalbumin | 2 |
49 | current/just-terminated | 2 |
50 | debride | 7 |
51 | debulk | 8 |
52 | delary | 1 |
53 | delay/prevent | 2 |
54 | diazotetramic | 1 |
55 | dii-negative | 1 |
56 | drug-use-related | 1 |
57 | eci™-guided | 1 |
58 | encoding/maintenance | 1 |
59 | evolutionary-derived | 1 |
60 | extracardial | 1 |
61 | forestall | 29 |
62 | gdm-a2 | 1 |
63 | gefitinib- | 1 |
64 | globalise | 1 |
65 | gmw | 2 |
66 | god/destiny | 1 |
67 | grip+tau | 1 |
68 | gtfb | 1 |
69 | gti-cn | 1 |
70 | halt | 214 |
71 | hemiarthropasty | 1 |
72 | hispa- | 1 |
73 | htlv-i/ii | 1 |
74 | icn80 | 1 |
75 | inassayability | 1 |
76 | increase-cardiovascular | 1 |
77 | laser-powered | 1 |
78 | lc3-positive | 1 |
79 | less-soluble | 1 |
80 | limited-incision | 1 |
81 | lopinavir/ritonavir- | 1 |
82 | lymphangioleiomyomatosis-related | 1 |
83 | lysozyme-induced | 1 |
84 | mbs-identified | 1 |
85 | mono-alpha-glucoside | 1 |
86 | msm-sensitive | 1 |
87 | music-delivering | 1 |
88 | non-bereavement | 2 |
89 | nonimmune-related | 1 |
90 | nontransthoracic | 1 |
91 | o-k-j-i-p | 1 |
92 | observation-alone | 1 |
93 | opioid-spare | 1 |
94 | orc/plnd | 1 |
95 | orthogenetic | 2 |
96 | overdiagnose | 4 |
97 | overthrow | 1 |
98 | par+uv-a | 1 |
99 | paraphrase | 1 |
100 | perineuraly | 1 |
101 | perirandomization | 1 |
102 | pique | 1 |
103 | pla- | 1 |
104 | placebo.only | 1 |
105 | podcast-only | 1 |
106 | postjoke | 1 |
107 | pre-empt | 8 |
108 | pre-external | 1 |
109 | pre-fc | 1 |
110 | pre/early | 1 |
111 | pregnancy/during | 1 |
112 | present- | 1 |
113 | prevent | 17,821 |
114 | prevent/delay | 5 |
115 | promiscuity/multiple | 1 |
116 | promote/support | 1 |
117 | ps-tt | 1 |
118 | pseudo-cushing | 1 |
119 | pyrrolidine-fused | 1 |
120 | r5.00 | 1 |
121 | re-formulate | 1 |
122 | reacquire | 1 |
123 | rebreed | 1 |
124 | reconfigure | 5 |
125 | reduce/prevent | 2 |
126 | rejuvenate | 7 |
127 | resorb | 2 |
128 | resuscitate/stabilise | 1 |
129 | retool | 2 |
130 | rf-b7.1 | 1 |
131 | rhamnose-glucose | 1 |
132 | routine-to-optional | 1 |
133 | selectebrain | 1 |
134 | self-dna | 1 |
135 | self-feed | 1 |
136 | self-prevent | 1 |
137 | sicken | 1 |
138 | sidelining | 1 |
139 | six-ring | 2 |
140 | sng | 1 |
141 | sones | 1 |
142 | splenopancreatic | 1 |
143 | sulphomethoxasol/trimethoprim | 1 |
144 | symbolize | 4 |
145 | tacrine- | 1 |
146 | tissue-volume | 2 |
147 | treatment-less | 1 |
148 | treatments-as-usual | 1 |
149 | uncircumcised-no | 1 |
150 | vadaskert | 1 |
151 | vildagliptin/metformin | 1 |
152 | zidovudine/lamivudine+efavirenz | 1 |
153 | zinc-insulin | 1 |
154 | ~44,000 | 1 |
155 | £30k | 1 |
156 | €951 | 1 |
1 | pla- | 1 |
2 | hispa- | 1 |
3 | gefitinib- | 1 |
4 | angled- | 1 |
5 | tacrine- | 1 |
6 | amoxycillin- | 1 |
7 | lopinavir/ritonavir- | 1 |
8 | present- | 1 |
9 | binary- | 1 |
10 | r5.00 | 1 |
11 | ~44,000 | 1 |
12 | 35.6/100 | 1 |
13 | 103,300 | 1 |
14 | 12.14.10 | 1 |
15 | 101,850 | 1 |
16 | 100tcid50 | 1 |
17 | icn80 | 1 |
18 | rf-b7.1 | 1 |
19 | €951 | 1 |
20 | 0.517±0.042 | 1 |
21 | gdm-a2 | 1 |
22 | c-23 | 1 |
23 | 91,183 | 1 |
24 | 32±3 | 1 |
25 | 3.3±2.4 | 1 |
26 | 6,724,284 | 1 |
27 | 0.14+/-0.35 | 1 |
28 | 0.93±0.65 | 1 |
29 | 49.06 | 1 |
30 | 16.0±11.16 | 1 |
31 | 36±16 | 1 |
32 | par+uv-a | 1 |
33 | self-dna | 1 |
34 | gtfb | 1 |
35 | resorb | 2 |
36 | pre-fc | 1 |
37 | nontransthoracic | 1 |
38 | diazotetramic | 1 |
39 | splenopancreatic | 1 |
40 | orthogenetic | 2 |
41 | lysozyme-induced | 1 |
42 | acidosis-induced | 1 |
43 | eci™-guided | 1 |
44 | self-feed | 1 |
45 | rebreed | 1 |
46 | mbs-identified | 1 |
47 | laser-powered | 1 |
48 | 5=preferred | 1 |
49 | pyrrolidine-fused | 1 |
50 | adpkd-associated | 1 |
51 | nonimmune-related | 1 |
52 | drug-use-related | 1 |
53 | lymphangioleiomyomatosis-related | 1 |
54 | current/just-terminated | 2 |
55 | evolutionary-derived | 1 |
56 | orc/plnd | 1 |
57 | encoding/maintenance | 1 |
58 | antecede | 2 |
59 | debride | 7 |
60 | mono-alpha-glucoside | 1 |
61 | postjoke | 1 |
62 | less-soluble | 1 |
63 | promiscuity/multiple | 1 |
64 | tissue-volume | 2 |
65 | cephazoline | 1 |
66 | continued-fluoxetine | 1 |
67 | observation-alone | 1 |
68 | opioid-spare | 1 |
69 | reacquire | 1 |
70 | reconfigure | 5 |
71 | paraphrase | 1 |
72 | globalise | 1 |
73 | resuscitate/stabilise | 1 |
74 | rhamnose-glucose | 1 |
75 | overdiagnose | 4 |
76 | re-formulate | 1 |
77 | rejuvenate | 7 |
78 | 'neonate | 1 |
79 | ameleriote | 1 |
80 | pique | 1 |
81 | bladder-invasive | 1 |
82 | dii-negative | 1 |
83 | msm-sensitive | 1 |
84 | lc3-positive | 1 |
85 | 'improve | 1 |
86 | symbolize | 4 |
87 | pseudo-cushing | 1 |
88 | 3,4-dihydro-2h-1,3-thiazine-containing | 1 |
89 | sidelining | 1 |
90 | six-ring | 2 |
91 | music-delivering | 1 |
92 | pregnancy/during | 1 |
93 | activity/resisting | 1 |
94 | sng | 1 |
95 | htlv-i/ii | 1 |
96 | £30k | 1 |
97 | debulk | 8 |
98 | extracardial | 1 |
99 | routine-to-optional | 1 |
100 | pre-external | 1 |
101 | treatments-as-usual | 1 |
102 | bls-level | 2 |
103 | forestall | 29 |
104 | retool | 2 |
105 | sulphomethoxasol/trimethoprim | 1 |
106 | butorphan | 1 |
107 | carpenter-coustan | 1 |
108 | gti-cn | 1 |
109 | sicken | 1 |
110 | selectebrain | 1 |
111 | zinc-insulin | 1 |
112 | vildagliptin/metformin | 1 |
113 | crystalloidsalbumin | 2 |
114 | aglaothamnion | 1 |
115 | limited-incision | 1 |
116 | anoxia/reoxygenation | 1 |
117 | perirandomization | 1 |
118 | uncircumcised-no | 1 |
119 | o-k-j-i-p | 1 |
120 | increase-cardiovascular | 1 |
121 | c.polykrikoides | 1 |
122 | sones | 1 |
123 | counter-sorcerers | 1 |
124 | 72-hours | 1 |
125 | 28-hours | 1 |
126 | treatment-less | 1 |
127 | control/suppress | 1 |
128 | confidential/anonymous | 1 |
129 | cat+act | 1 |
130 | halt | 214 |
131 | antihormone-resistant | 1 |
132 | non-bereavement | 2 |
133 | prevent | 17,821 |
134 | self-prevent | 1 |
135 | reduce/prevent | 2 |
136 | delay/prevent | 2 |
137 | chemoprevent | 1 |
138 | pre-empt | 8 |
139 | vadaskert | 1 |
140 | promote/support | 1 |
141 | ps-tt | 1 |
142 | 1,500u | 1 |
143 | grip+tau | 1 |
144 | gmw | 2 |
145 | overthrow | 1 |
146 | prevent/delay | 5 |
147 | bioverify | 1 |
148 | perineuraly | 1 |
149 | podcast-only | 1 |
150 | placebo.only | 1 |
151 | pre/early | 1 |
152 | god/destiny | 1 |
153 | delary | 1 |
154 | inassayability | 1 |
155 | hemiarthropasty | 1 |
156 | zidovudine/lamivudine+efavirenz | 1 |